12 april 2024: Voor wie is geinteresseerd in Ultra Sound behandeling van levertumoren lees dit artikel. Met onderaan in artikel contactadres van arts Matteo Fusaglia die in het Antoni van Leeuwenhoek ziekenhuis voor het NKI de studie met Ultra Sound bij Intra-operatieve navigatie gaat uitvoeren voor zijn promotieonderzoek.

4 februari 2021: zie ook dit artikel: https://kanker-actueel.nl/zelflerende-algoritmen-leiden-tot-optimale-effectiviteit-van-door-hifu-ultra-sound-opgewekte-hyperthermie-bij-kwaadaardige-tumoren-aldus-daniel-deelen-in-zijn-proefschrift.html

In Nederland wordt in deze privekliniek HIFU toegepast bij prostaatkanker

Deze reviewstudie uit 2019 geeft overzicht van studies gedaan met HIFU wereldwijd.

19 juni 2019: lees ook dit artikel:

https://kanker-actueel.nl/opereren-zonder-snijden-met-bv-tace-rfa-nanoknife-yttrium-90-cryoablatie-enz-doe-een-consult-bij-specialistisch-team-in-nederland-voordat-u-naar-het-buitenland-op-zoek-gaat.html

20 november 2017: lees ook dit artikel:

https://kanker-actueel.nl/hifu-high-intensity-focused-ultrasound-is-uitstekende-behandeling-voor-niet-uitgezaaide-prostaatkanker-waarom-blijft-dit-een-experimentele-behandeling-en-wordt-hifu-niet-vergoed-vanuit-basisverzekering.html

Zie ook gerelateerde artikelen

De verwijzingen naar de studies in het UMC van zowel Ultra Sound (MR-HIFU) bij borstkanker als bij botuitzaaiingen bij prostaatkanker (zie hieronder) geven geen website pagina meer. De studie bij borstkanker is afgesloten, die bij botmetastases waarschijnlijk ook want vind deze niet meer op de website van het UMC Utrecht en ook niet meer in clinical trials.

Maar voor de studie bij borstkanker zie deze publicatie:Nieuw onderzoek toont potentie MR-HIFU technologie voor nieuwe kankertherapie waarin de studie met borstkanker is verwerkt. Zie ook in dit verband deze studie: Nicole Hijnen et al., Thermal combination therapies for local drug delivery by magnetic resonance-guided high-intensity focused ultrasound, (PNAS, 31 mei 2017).

Een studie van Ultra Sound (MR-HIFU) bij botuitzaaiingen van de Nederlandse onderzoekers betrokken bij onderstaand omschreven onderzoek bij prostaatkankerpatiënten is deze: Quality of MR thermometry during palliative MR-guided high-intensity focused ultrasound (MR-HIFU) treatment of bone metastase

Het volledige studierapport is gratis in te zien met gedetailleerde omschrijvingen van hoe Ultra Sound werkt en ook grafieken van behandelde patienten. En uitstekende referentielijst.

13 augustus 2013: Bron: UMC Utrecht

Foto: behandeling van botmetastase in bot via HIFU

13 augustus 2015: wat veel mensen niet weten en waar patiënten ook zelden op wordt gewezen is deze studie in het UMC Utrecht die al enkele jaren loopt, zie ook meer info over HIFU in gerelateerde artikelen:

MR-HIFU bij pijnlijke botuitzaaiingen

UMC Utrecht

MR-HIFU (Magnetic Resonance Imaging-guided High Intensity Focused Ultrasound) is een nieuwe behandelmethode voor pijnlijke botuitzaaiingen. Het gaat om een behandeling, met het doel de pijn te verminderen en kwaliteit van leven te behouden of waar mogelijk te verbeteren. De behandeling wordt alleen toegepast bij patiënten in de palliatieve fase, dit wil zeggen dat zij met de reguliere behandelingen niet meer beter kunnen worden. MR-HIFU is goedgekeurd als veilige behandeling voor patiënten met pijnlijke botuitzaaiingen.

Contact en vragen

2 oktober 2012: met veel publiciteit werd vandaag het behandelen met ultra sound bij een vrouw met beginnende borstkanker in het UMC in alle media gemeld. Alsof deze aanpak iets nieuws zou zijn. Ultra sound - HIFU wordt al vele vele jaren toegepast bij prostaatkanker en ook bij levertumoren. Dus zo nieuw is die aanpak niet.

12 mei 2012: Bron: Radiology. 2011 Apr;259(1):39-56.

Het weghalen van tumoren via de zogeheten HIFU - High dose Focused Ultra Sound heeft soms de voorkeur boven een meer traditionelere RFA - Radio Frequency Ablation. Hieronder het abstract van een overview studie die goed laat zien in wanneer en waarom gekozen kan worden voor ultra sound. Het abstract is kort maar klik hier voor het volledige studierapport dat gratis is in te zien met heldere foto's en uitstekende onderbouwde informatie. Bijgevoegd een referentielijst van 149 studies.

Focused Ultrasound Surgery in Oncology: Overview and Principles

Radiology. 2011 Apr;259(1):39-56.

Focused ultrasound surgery in oncology: overview and principles.

Tempany CM, McDannold NJ, Hynynen K, Jolesz FA.

Source

Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, Room 050, L1, Boston, MA 02129, USA. ctempany@bwh.harvard.edu

Abstract

Focused ultrasound surgery (FUS) is a noninvasive image-guided therapy and an alternative to surgical interventions. It presents an opportunity to revolutionize cancer therapy and to affect or change drug delivery of therapeutic agents in new focally targeted ways. In this article the background, principles, technical devices, and clinical cancer applications of image-guided FUS are reviewed.

PMID:: 21436096; [PubMed - indexed for MEDLINE]
PMCID:: PMC3064817

References

1. Wood RW, Loomis AL. The physical and biological effects of high frequency sound waves of great intensity. Philos Mag Ser 7 1927;4(22):417–436.

2. Seabrook W. Doctor Wood, modern wizard of the laboratory: the story of an American small boy who became the most daring and original experimental physicist of our day—but never grew up. New York, NY: Harcourt, Brace, 1941.

3. Moonen CT. Spatio-temporal control of gene expression and cancer treatment using magnetic resonance imaging-guided focused ultrasound. Clin Cancer Res 2007;13(12):3482–3489. [PubMed]

4. McDannold NJ, Jolesz FA. Magnetic resonance image-guided thermal ablations. Top Magn Reson Imaging 2000;11(3):191–202. [PubMed]

5. Lindner JR, Jr, Song J, Christiansen J, Klibanov AL, Xu F, Ley K. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation 2001;104(17):2107–2112. [PubMed]

6. Klibanov AL. Preparation of targeted microbubbles: ultrasound contrast agents for molecular imaging. Med Biol Eng Comput 2009;47(8):875–882. [PubMed]

7. Böhmer MR, Klibanov AL, Tiemann K, Hall CS, Gruell H, Steinbach OC. Ultrasound triggered image-guided drug delivery. Eur J Radiol 2009;70(2):242–253. [PubMed]

8. Lynn JG, Zwemer RL, Chick AJ, Miller AE. A new method for the generation and use of focused ultrasound in experimental biology. J Gen Physiol 1942;26(2):179–193. [PMC free article] [PubMed]

9. Meyers R, Fry WJ, Fry FJ, Dreyer LL, Schultz DF, Noyes RF. Early experiences with ultrasonic irradiation of the pallidofugal and nigral complexes in hyperkinetic and hypertonic disorders. J Neurosurg 1959;16(1):32–54. [PubMed]

10. Fry WJ, Fry FJ. Fundamental neurological research and human neurosurgery using intense ultrasound. IRE Trans Med Electron 1960;ME-7:166–181. [PubMed]

11. Cline HE, Schenck JF, Hynynen K, Watkins RD, Souza SP, Jolesz FA. MR-guided focused ultrasound surgery. J Comput Assist Tomogr 1992;16(6):956–965. [PubMed]

12. Hynynen K, Damianou C, Darkazanli A, Unger E, Schenck JF. The feasibility of using MRI to monitor and guide noninvasive ultrasound surgery. Ultrasound Med Biol 1993;19(1):91–92. [PubMed]

13. Cline HE, Hynynen K, Watkins RD, et al. Focused US system for MR imaging-guided tumor ablation. Radiology 1995;194(3):731–737. [PubMed]

14. Cline HE, Schenck JF, Watkins RD, Hynynen K, Jolesz FA. Magnetic resonance-guided thermal surgery. Magn Reson Med 1993;30(1):98–106. [PubMed]

15. Wells P. Biomedical ultrasound. Boston, Mass: Academic Press, 1977.

16. Lehmann JF, DeLateur BJ, Warren CG, Stonebridge JS. Heating produced by ultrasound in bone and soft tissue. Arch Phys Med Rehabil 1967;48(8):397–401. [PubMed]

17. Hynynen K, DeYoung D. Temperature elevation at muscle-bone interface during scanned, focused ultrasound hyperthermia. Int J Hyperthermia 1988;4(3):267–279. [PubMed]

18. Ebbini ES, Cain CA. Multiple-focus ultrasound phased-array pattern synthesis: optimal driving-signal distributions for hyperthermia. IEEE Trans Ultrason Ferroelectr Freq Control 1989;36(5):540–548. [PubMed]

19. Fan X, Hynynen K. A study of various parameters of spherically curved phased arrays for noninvasive ultrasound surgery. Phys Med Biol 1996;41(4):591–608. [PubMed]

20. Wan H, VanBaren P, Ebbini ES, Cain CA. Ultrasound surgery: comparison of strategies using phased array systems. IEEE Trans Ultrason Ferroelectr Freq Control 1996;43(6):1085–1098.

21. Fjield T, Hynynen K. The combined concentric-ring and sector-vortex phased array for MRI guided ultrasound surgery. IEEE Trans Ultrason Ferroelectr Freq Control 1997;44(5):1157–1167.

22. Hutchinson EB, Hynynen K. Intracavitary ultrasound phased arrays for prostate thermal therapies: MRI compatibility and in vivo testing. Med Phys 1998;25(12):2392–2399. [PubMed]

23. Dorr LN, Hynynen K. The effects of tissue heterogeneities and large blood vessels on the thermal exposure induced by short high-power ultrasound pulses. Int J Hyperthermia 1992;8(1):45–59. [PubMed]

24. Yang R, Sanghvi NT, Rescorla FJ, Kopecky KK, Grosfeld JL. Liver cancer ablation with extracorporeal high-intensity focused ultrasound. Eur Urol 1993;23(Suppl 1):17–22. [PubMed]

25. Kolios MC, Sherar MD, Hunt JW. Blood flow cooling and ultrasonic lesion formation. Med Phys 1996;23(7):1287–1298. [PubMed]

26. Moritz AR, Henriques FC. Studies of thermal injury: II. The relative importance of time and surface temperature in the causation of cutaneous burns. Am J Pathol 1947;23(5):695–720. [PMC free article] [PubMed]

27. Crile G., Jr The effects of heat and radiation on cancers implanted on the feet of mice. Cancer Res 1963;23:372–380. [PubMed]

28. Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 1984;10(6):787–800. [PubMed]

29. Landry J, Marceau N. Rate-limiting events in hyperthermic cell killing. Radiat Res 1978;75(3):573–585. [PubMed]

30. Lele P. Threshold and mechanisms of ultrasonic damage to organized animal tissues. Presented at the Symposium on Biological Effects and Characterizations of Ultrasound Sources, Rockville, Md, 1977.

31. Hynynen K, Darkazanli A, Damianou CA, Unger E, Schenck JF. The usefulness of a contrast agent and gradient-recalled acquisition in a steady-state imaging sequence for magnetic resonance imaging-guided noninvasive ultrasound surgery. Invest Radiol 1994;29(10):897–903. [PubMed]

32. Moonen CT, Madio DP, de Zwart JA, et al. MRI-guided focused ultrasound as a potential tool for control of gene therapy. Eur Radiol 1997;7:1165.

33. O’Neill BE, Li KC. Augmentation of targeted delivery with pulsed high intensity focused ultrasound. Int J Hyperthermia 2008;24(6):506–520. [PubMed]

34. Vykhodtseva N, McDannold N, Hynynen K. Induction of apoptosis in vivo in the rabbit brain with focused ultrasound and Optison. Ultrasound Med Biol 2006;32(12):1923–1929. [PubMed]

35. Coakley A. Acoustical detection of single cavitation events in a focused field in water at 1 MHz. J Acoust Soc Am 1971;49(3B):792–801.

36. Frizzell LA, Lee CS, Aschenbach PD, Borrelli MJ, Morimoto RS, Dunn F. Involvement of ultrasonically induced cavitation in the production of hind limb paralysis of the mouse neonate. J Acoust Soc Am 1983;74(3):1062–1065. [PubMed]

37. ter Haar G, Daniels S, Eastaugh KC, Hill CR. Ultrasonically induced cavitation in vivo. Br J Cancer Suppl 1982;5:151–155. [PMC free article] [PubMed]

38. Smith NB, Hynynen K. The feasibility of using focused ultrasound for transmyocardial revascularization. Ultrasound Med Biol 1998;24(7):1045–1054. [PubMed]

39. Xu Z, Ludomirsky A, Eun LY, et al. Controlled ultrasound tissue erosion. IEEE Trans Ultrason Ferroelectr Freq Control 2004;51(6):726–736. [PMC free article] [PubMed]

40. Parsons JE, Cain CA, Abrams GD, Fowlkes JB. Pulsed cavitational ultrasound therapy for controlled tissue homogenization. Ultrasound Med Biol 2006;32(1):115–129. [PubMed]

41. Vykhodtseva NI, Hynynen K, Damianou C. Histologic effects of high intensity pulsed ultrasound exposure with subharmonic emission in rabbit brain in vivo. Ultrasound Med Biol 1995;21(7):969–979. [PubMed]

42. Hynynen K, Chung AH, Colucci V, Jolesz FA. Potential adverse effects of high-intensity focused ultrasound exposure on blood vessels in vivo. Ultrasound Med Biol 1996;22(2):193–201. [PubMed]

43. Hynynen K, Colucci V, Chung A, Jolesz F. Noninvasive arterial occlusion using MRI-guided focused ultrasound. Ultrasound Med Biol 1996;22(8):1071–1077. [PubMed]

44. Umemura SI, Yumita N, Nishigaki R, Umemura K. Sonochemical activation of hematoporphyrin: a potential modality for cancer treatment. Proc IEEE Ultrason Symp 1989;2:955–960.

45. Siegel RJ, Cumberland DC, Myler RK, DonMichael TA. Percutaneous ultrasonic angioplasty: initial clinical experience. Lancet 1989;2(8666):772–774 [Published correction appears in Lancet 1989;2(8677):1468.] [PubMed]

46. Rosenschein U, Bernstein JJ, DiSegni E, Kaplinsky E, Bernheim J, Rozenzsajn LA. Experimental ultrasonic angioplasty: disruption of atherosclerotic plaques and thrombi in vitro and arterial recanalization in vivo. J Am Coll Cardiol 1990;15(3):711–717. [PubMed]

47. Kim HJ, Greenleaf JF, Kinnick RR, Bronk JT, Bolander ME. Ultrasound-mediated transfection of mammalian cells. Hum Gene Ther 1996;7(11):1339–1346. [PubMed]

48. Bednarski MD, Lee JW, Callstrom MR, Li KC. In vivo target-specific delivery of macromolecular agents with MR-guided focused ultrasound. Radiology 1997;204(1):263–268. [PubMed]

49. Frenkel V, Oberoi J, Stone MJ, et al. Pulsed high-intensity focused ultrasound enhances thrombolysis in an in vitro model. Radiology 2006;239(1):86–93. [PMC free article] [PubMed]

50. Stone MJ, Frenkel V, Dromi S, et al. Pulsed-high intensity focused ultrasound enhanced tPA mediated thrombolysis in a novel in vivo clot model, a pilot study. Thromb Res 2007;121(2):193–202. [PMC free article] [PubMed]

51. Khan Y, Laurencin CT. Fracture repair with ultrasound: clinical and cell-based evaluation. J Bone Joint Surg Am 2008;90(Suppl 1):138–144. [PubMed]

52. Rutten S, Nolte PA, Korstjens CM, Klein-Nulend J. Low-intensity pulsed ultrasound affects RUNX2 immunopositive osteogenic cells in delayed clinical fracture healing. Bone 2009;45(5):862–869. [PubMed]

53. Haar GT, Coussios C. High intensity focused ultrasound: past, present and future. Int J Hyperthermia 2007;23(2):85–87. [PubMed]

54. Wu F. Extracorporeal high intensity focused ultrasound in the treatment of patients with solid malignancy. Minim Invasive Ther Allied Technol 2006;15(1):26–35. [PubMed]

55. Rouvière O, Souchon R, Salomir R, Gelet A, Chapelon JY, Lyonnet D. Transrectal high-intensity focused ultrasound ablation of prostate cancer: effective treatment requiring accurate imaging. Eur J Radiol 2007;63(3):317–327. [PubMed]

56. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007;57(2):75–89. [PubMed]

57. Seip R, VanBaren P, Cain CA, Ebbini ES. Noninvasive real-time multipoint temperature control for ultrasound phased array treatments. IEEE Trans Ultrason Ferroelectr Freq Control 1996;43(6):1063–1073.

58. Curiel L, Chopra R, Hynynen K. In vivo monitoring of focused ultrasound surgery using local harmonic motion. Ultrasound Med Biol 2009;35(1):65–78. [PMC free article] [PubMed]

59. Orsi F, Zhang L, Arnone P, et al. High-intensity focused ultrasound ablation: effective and safe therapy for solid tumors in difficult locations. AJR Am J Roentgenol 2010;195(3):W245–W252. [PubMed]

60. Salomir R, Delemazure AS, Palussière J, Rouvière O, Cotton F, Chapelon JY. Image-based control of the magnetic resonance imaging-guided focused ultrasound thermotherapy. Top Magn Reson Imaging 2006;17(3):139–151. [PubMed]

61. McDannold N, Tempany C, Jolesz F, Hynynen K. Evaluation of referenceless thermometry in MRI-guided focused ultrasound surgery of uterine fibroids. J Magn Reson Imaging 2008;28(4):1026–1032. [PMC free article] [PubMed]

62. Higuchi N, Bleier AR, Jolesz FA, Colucci VM, Morris JH. Magnetic resonance imaging of the acute effects of interstitial neodymium:YAG laser irradiation on tissues. Invest Radiol 1992;27(10):814–821. [PubMed]

63. Bleier AR, Jolesz FA, Cohen MS, et al. Real-time magnetic resonance imaging of laser heat deposition in tissue. Magn Reson Med 1991;21(1):132–137. [PubMed]

64. Hindman JC. Proton resonance shift of water in the gas and liquid states. J Chem Phys 1966;44(12):4582–4592.

65. Ishihara Y, Calderon A, Watanabe H, et al. A precise and fast temperature mapping using water proton chemical shift. Magn Reson Med 1995;34(6):814–823. [PubMed]

66. Peters RD, Hinks RS, Henkelman RM. Ex vivo tissue-type independence in proton-resonance frequency shift MR thermometry. Magn Reson Med 1998;40(3):454–459. [PubMed]

67. Kuroda K, Chung AH, Hynynen K, Jolesz FA. Calibration of water proton chemical shift with temperature for noninvasive temperature imaging during focused ultrasound surgery. J Magn Reson Imaging 1998;8(1):175–181. [PubMed]

68. Pilatou MC, Stewart EA, Maier SE, et al. MRI-based thermal dosimetry and diffusion-weighted imaging of MRI-guided focused ultrasound thermal ablation of uterine fibroids. J Magn Reson Imaging 2009;29(2):404–411. [PMC free article] [PubMed]

69. Daum DR, Hynynen K. A 256-element ultrasonic phased array system for the treatment of large volumes of deep seated tissue. IEEE Trans Ultrason Ferroelectr Freq Control 1999;46(5):1254–1268. [PubMed]

70. Hynynen K, Jolesz FA. Demonstration of potential noninvasive ultrasound brain therapy through an intact skull. Ultrasound Med Biol 1998;24(2):275–283. [PubMed]

71. Hynynen K, Clement GT, McDannold N, et al. 500-element ultrasound phased array system for noninvasive focal surgery of the brain: a preliminary rabbit study with ex vivo human skulls. Magn Reson Med 2004;52(1):100–107. [PubMed]

72. Hata T, Takahashi H, Watanabe K, et al. Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography. J Am Coll Surg 2004;198(2):190–197. [PubMed]

73. Uematsu T, Yuen S, Kasami M, Uchida Y. Comparison of magnetic resonance imaging, multidetector row computed tomography, ultrasonography, and mammography for tumor extension of breast cancer. Breast Cancer Res Treat 2008;112(3):461–474. [PubMed]

74. Schnall M. MR imaging evaluation of cancer extent: is there clinical relevance? Magn Reson Imaging Clin N Am 2006;14(3):379–381, vii. [PubMed]

75. Grobmyer SR, Mortellaro VE, Marshall J, et al. Is there a role for routine use of MRI in selection of patients for breast-conserving cancer therapy? J Am Coll Surg 2008;206(5):1045–1050; discussion 1050–1052. [PubMed]

76. Hynynen K, Pomeroy O, Smith DN, et al. MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. Radiology 2001;219(1):176–185. [PubMed]

77. Schmitz AC, Gianfelice D, Daniel BL, Mali WP, van den Bosch MA. Image-guided focused ultrasound ablation of breast cancer: current status, challenges, and future directions. Eur Radiol 2008;18(7):1431–1441. [PMC free article] [PubMed]

78. Gombos EC, Kacher DF, Furusawa H, Namba K. Breast focused ultrasound surgery with magnetic resonance guidance. Top Magn Reson Imaging 2006;17(3):181–188. [PubMed]

79. Gianfelice D, Khiat A, Amara M, Belblidia A, Boulanger Y. MR imaging-guided focused US ablation of breast cancer: histopathologic assessment of effectiveness— initial experience. Radiology 2003;227(3):849–855. [PubMed]

80. Wu F, Wang ZB, Cao YD, et al. A randomised clinical trial of high-intensity focused ultrasound ablation for the treatment of patients with localised breast cancer. Br J Cancer 2003;89(12):2227–2233. [PMC free article] [PubMed]

81. Wu F, Chen WZ, Bai J, et al. Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol 2001;27(8):1099–1106. [PubMed]

82. Furusawa H, Namba K, Nakahara H, et al. The evolving non-surgical ablation of breast cancer: MR guided focused ultrasound (MRgFUS). Breast Cancer 2007;14(1):55–58. [PubMed]

83. Kennedy JE, Wu F, ter Haar GR, et al. High-intensity focused ultrasound for the treatment of liver tumours. Ultrasonics 2004;42(1-9):931–935. [PubMed]

84. Zhang L, Fan WJ, Huang JH, et al. Comprehensive sequential interventional therapy for hepatocellular carcinoma. Chin Med J (Engl) 2009;122(19):2292–2298. [PubMed]

85. Fischer K, Gedroyc W, Jolesz FA. Focused ultrasound as a local therapy for liver cancer. Cancer J 2010;16(2):118–124. [PubMed]

86. Civale J, Clarke R, Rivens I, ter Haar G. The use of a segmented transducer for rib sparing in HIFU treatments. Ultrasound Med Biol 2006;32(11):1753–1761. [PubMed]

87. Zhu H, Zhou K, Zhang L, et al. High intensity focused ultrasound (HIFU) therapy for local treatment of hepatocellular carcinoma: role of partial rib resection. Eur J Radiol 2009;72(1):160–166. [PubMed]

88. ter Haar G. High intensity ultrasound. Semin Laparosc Surg 2001;8(1):77–89. [PubMed]

89. Jolesz FA, Hynynen K, McDannold N, Freundlich D, Kopelman D. Noninvasive thermal ablation of hepatocellular carcinoma by using magnetic resonance imaging-guided focused ultrasound. Gastroenterology 2004;127(5 Suppl 1):S242–S247. [PubMed]

90. Mikami K, Murakami T, Okada A, Osuga K, Tomoda K, Nakamura H. Magnetic resonance imaging-guided focused ultrasound ablation of uterine fibroids: early clinical experience. Radiat Med 2008;26(4):198–205. [PubMed]

91. Gedroyc WM. New clinical applications of magnetic resonance-guided focused ultrasound. Top Magn Reson Imaging 2006;17(3):189–194. [PubMed]

92. Wu F, Wang ZB, Chen WZ, et al. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology 2005;235(2):659–667. [PubMed]

93. Holbrook AB, Santos JM, Kaye E, Rieke V, Pauly KB. Real-time MR thermometry for monitoring HIFU ablations of the liver. Magn Reson Med 2010;63(2):365–373. [PMC free article] [PubMed]

94. Fennessy FM, Tuncali K, Morrison PR, Tempany CM. MR imaging-guided interventions in the genitourinary tract: an evolving concept. Magn Reson Imaging Clin N Am 2010;18(1):11–28. [PubMed]

95. Thüroff S, Chaussy C, Vallancien G, et al. High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol 2003;17(8):673–677. [PubMed]

96. Blana A, Murat FJ, Walter B, et al. First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer. Eur Urol 2008;53(6):1194–1201. [PubMed]

97. Misraï V, Rouprêt M, Chartier-Kastler E, et al. Oncologic control provided by HIFU therapy as single treatment in men with clinically localized prostate cancer. World J Urol 2008;26(5):481–485. [PubMed]

98. Uchida T, Ohkusa H, Yamashita H, et al. Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer. Int J Urol 2006;13(3):228–233. [PubMed]

99. Seip R, Ebbini ES. Noninvasive estimation of tissue temperature response to heating fields using diagnostic ultrasound. IEEE Trans Biomed Eng 1995;42(8):828–839. [PubMed]

100. Maass-Moreno R, Damianou CA, Sanghvi NT. Noninvasive temperature estimation in tissue via ultrasound echo-shifts. Part II. In vitro study. J Acoust Soc Am 1996;100(4 Pt 1):2522–2530. [PubMed]

101. Pernot M, Tanter M, Bercoff J, Waters KR, Fink M. Temperature estimation using ultrasonic spatial compound imaging. IEEE Trans Ultrason Ferroelectr Freq Control 2004;51(5):606–615. [PubMed]

102. Farny CH, Clement GT. Feasibility of ultrasound phase contrast for heating localization. J Acoust Soc Am 2008;123(3):1773–1783. [PubMed]

103. Curiel L, Souchon R, Rouvière O, Gelet A, Chapelon JY. Elastography for the follow-up of high-intensity focused ultrasound prostate cancer treatment: initial comparison with MRI. Ultrasound Med Biol 2005;31(11):1461–1468. [PubMed]

104. Madersbacher S, Kratzik C, Szabo N, Susani M, Vingers L, Marberger M. Tissue ablation in benign prostatic hyperplasia with high-intensity focused ultrasound. Eur Urol 1993;23(Suppl 1):39–43. [PubMed]

105. Sokka SD, King R, Hynynen K. MRI-guided gas bubble enhanced ultrasound heating in in vivo rabbit thigh. Phys Med Biol 2003;48(2):223–241. [PubMed]

106. McDannold N, Ziso H, Assif B, et al. MRI-guided focused ultrasound (MRgFUS) system for thermal ablation of prostate cancer: Pre-clinical evaluation in canines . In: Proceedings of the 17th Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2009.

107. Kinsey AM, Diederich CJ, Rieke V, et al. Transurethral ultrasound applicators with dynamic multi-sector control for prostate thermal therapy: in vivo evaluation under MR guidance. Med Phys 2008;35(5):2081–2093. [PMC free article] [PubMed]

108. Chopra R, Baker N, Choy V, et al. MRI-compatible transurethral ultrasound system for the treatment of localized prostate cancer using rotational control. Med Phys 2008;35(4):1346–1357. [PubMed]

109. Chopra R, Bronskill M, Haider M, Klotz L. Preliminary human evaluation of MRI-guided transurethral ultrasound therapy for the treatment of localized prostate cancer . In: Proceedings of the 18th Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2010.

110. Wong PYH, Hata N, Szot Barnes A, et al. Displacement of neurovascular bundles before and after MRI-guided prostate brachytherapy . In: Proceedings of the 15th Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2007.

111. Kelloff GJ, Choyke P, Coffey DS.; Prostate Cancer Imaging Working Group Challenges in clinical prostate cancer: role of imaging. AJR Am J Roentgenol 2009;192(6):1455–1470. [PMC free article] [PubMed]

112. Afnan J, Tempany CM. Update on prostate imaging. Urol Clin North Am 2010;37(1):23–25. [PMC free article] [PubMed]

113. Liberman B, Gianfelice D, Inbar Y, et al. Pain palliation in patients with bone metastases using MR-guided focused ultrasound surgery: a multicenter study. Ann Surg Oncol 2009;16(1):140–146. [PubMed]

114. Meng X, He G, Zhang J, et al. A comparative study of fibroid ablation rates using radio frequency or high-intensity focused ultrasound. Cardiovasc Intervent Radiol 2010;33(4):794–799. [PubMed]

115. Tempany CM, Stewart EA, McDannold N, Quade BJ, Jolesz FA, Hynynen K. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology 2003;226(3):897–905. [PubMed]

116. Ren XL, Zhou XD, Yan RL, et al. Sonographically guided extracorporeal ablation of uterine fibroids with high-intensity focused ultrasound: midterm results. J Ultrasound Med 2009;28(1):100–103. [PubMed]

117. Shen SH, Fennessy F, McDannold N, Jolesz F, Tempany C. Image-guided thermal therapy of uterine fibroids. Semin Ultrasound CT MR 2009;30(2):91–104. [PMC free article] [PubMed]

118. Hindley J, Gedroyc WM, Regan L, et al. MRI guidance of focused ultrasound therapy of uterine fibroids: early results. AJR Am J Roentgenol 2004;183(6):1713–1719 [Published correction appears in AJR Am J Roentgenol 2005;184(1):348.] [PubMed]

119. Stewart EA, Rabinovici J, Tempany CM, et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril 2006;85(1):22–29 [Published correction appears in Fertil Steril 2006;85(4):1072.] [PubMed]

120. Fennessy FM, Tempany CM. MRI-guided focused ultrasound surgery of uterine leiomyomas. Acad Radiol 2005;12(9):1158–1166. [PubMed]

121. Fennessy FM, Tempany CM, McDannold NJ, et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery—results of different treatment protocols. Radiology 2007;243(3):885–893. [PubMed]

122. Stewart EA, Gostout B, Rabinovici J, Kim HS, Regan L, Tempany CM. Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol 2007;110(2 Pt 1):279–287. [PubMed]

123. Morita Y, Ito N, Hikida H, Takeuchi S, Nakamura K, Ohashi H. Non-invasive magnetic resonance imaging-guided focused ultrasound treatment for uterine fibroids - early experience. Eur J Obstet Gynecol Reprod Biol 2008;139(2):199–203. [PubMed]

124. Leon-Villapalos J, Kaniorou-Larai M, Dziewulski P. Full thickness abdominal burn following magnetic resonance guided focused ultrasound therapy. Burns 2005;31(8):1054–1055. [PubMed]

125. Morita Y, Ito N, Ohashi H. Pregnancy following MR-guided focused ultrasound surgery for a uterine fibroid. Int J Gynaecol Obstet 2007;99(1):56–57. [PubMed]

126. Gavrilova-Jordan LP, Rose CH, Traynor KD, Brost BC, Gostout BS. Successful term pregnancy following MR-guided focused ultrasound treatment of uterine leiomyoma. J Perinatol 2007;27(1):59–61. [PubMed]

127. Damianou C, Hynynen K. Focal spacing and near-field heating during pulsed high temperature ultrasound therapy. Ultrasound Med Biol 1993;19(9):777–787. [PubMed]

128. Arora D, Minor MA, Skliar M, Roemer RB. Control of thermal therapies with moving power deposition field. Phys Med Biol 2006;51(5):1201–1219. [PubMed]

129. Mougenot C, Salomir R, Palussière J, Grenier N, Moonen CT. Automatic spatial and temporal temperature control for MR-guided focused ultrasound using fast 3D MR thermometry and multispiral trajectory of the focal point. Magn Reson Med 2004;52(5):1005–1015. [PubMed]

130. Kopelman D, Inbar Y, Hanannel A, et al. Magnetic resonance-guided focused ultrasound surgery using an enhanced sonication technique in a pig muscle model. Eur J Radiol 2006;59(2):190–197. [PubMed]

131. Holt RG, Roy RA. Measurements of bubble-enhanced heating from focused, MHz-frequency ultrasound in a tissue-mimicking material. Ultrasound Med Biol 2001;27(10):1399–1412. [PubMed]

132. Okada A, Morita Y, Fukunishi H, Takeichi K, Murakami T. Non-invasive magnetic resonance-guided focused ultrasound treatment of uterine fibroids in a large Japanese population: impact of the learning curve on patient outcome. Obstet Gynecol 2009;34(5):579–583.

133. Lele PP. A simple method for production of trackless focal lesions with focused ultrasound: physical factors. J Physiol (Paris) 1962;160:494–512.

134. Ram Z, Cohen ZR, Harnof S, et al. Magnetic resonance imaging-guided, high-intensity focused ultrasound for brain tumor therapy. Neurosurgery 2006;59(5):949–955; discussion 955–956. [PubMed]

135. Marquet F, Pernot M, Aubry JF, et al. Non-invasive transcranial ultrasound therapy based on a 3D CT scan: protocol validation and in vitro results. Phys Med Biol 2009;54(9):2597–2613. [PubMed]

136. Aubry JF, Tanter M, Pernot M, Thomas JL, Fink M. Experimental demonstration of noninvasive transskull adaptive focusing based on prior computed tomography scans. J Acoust Soc Am 2003;113(1):84–93. [PubMed]

137. Hynynen K, McDannold N, Vykhodtseva N, et al. Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery. J Neurosurg 2006;105(3):445–454. [PubMed]

138. McDannold N, Clement GT, Black P, Jolesz F, Hynynen K. Transcranial magnetic resonance imaging-guided focused ultrasound surgery of brain tumors: initial findings in 3 patients. Neurosurgery 2010;66(2):323–332; discussion 332. [PMC free article] [PubMed]

139. Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 2001;220(3):640–646. [PubMed]

140. McDannold NJ, Vykhodtseva NI, Hynynen K. Microbubble contrast agent with focused ultrasound to create brain lesions at low power levels: MR imaging and histologic study in rabbits. Radiology 2006;241(1):95–106. [PubMed]

141. Guerin C, Olivi A, Weingart JD, Lawson HC, Brem H. Recent advances in brain tumor therapy: local intracerebral drug delivery by polymers. Invest New Drugs 2004;22(1):27–37. [PubMed]

142. Pardridge WM. Drug and gene delivery to the brain: the vascular route. Neuron 2002;36(4):555–558. [PubMed]

143. Sheikov N, McDannold N, Vykhodtseva N, Jolesz F, Hynynen K. Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles. Ultrasound Med Biol 2004;30(7):979–989. [PubMed]

144. Kinoshita M, McDannold N, Jolesz FA, Hynynen K. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound. Biochem Biophys Res Commun 2006;340(4):1085–1090. [PubMed]

145. Kinoshita M, McDannold N, Jolesz FA, Hynynen K. Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption. Proc Natl Acad Sci U S A 2006;103(31):11719–11723. [PMC free article] [PubMed]

146. Hynynen K, McDannold N, Sheikov NA, Jolesz FA, Vykhodtseva N. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage 2005;24(1):12–20. [PubMed]

147. Bradley WG., Jr MR-guided focused ultrasound: a potentially disruptive technology. J Am Coll Radiol 2009;6(7):510–513. [PubMed]

148. Jolesz FA, McDannold N. Current status and future potential of MRI-guided focused ultrasound surgery. J Magn Reson Imaging 2008;27(2):391–399. [PubMed]

149. McDannold N, Tempany CM, Fennessy FM, et al. Uterine leiomyomas: MR imaging-based thermometry and thermal dosimetry during focused ultrasound thermal ablation. Radiology 2006;240(1):263–272. [PMC free article] [PubMed]